Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesOff-label use of omalizumab in non-asthma conditions: new opportunities
Expert Review of Respiratory Medicine, 06/18/09
Morjaria JB et al. - In this reveiw, the authors evaluate the evidence in support of a more extensive role for omalizumab in a number of non-asthma IgE-related conditions, and particularly where intensive treatment has not been effective. However, studies with larger numbers of well-characterized patients will be necessary to provide sound evidence regarding the benefit of IgE blockade in these challenging conditions.
Related Articles
Reduced FcεRI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy
International Archives of Allergy and Immunology, 10/21/09
Relevance Score: 87%
Relationship between pretreatment specific IgE and the response to omalizumab therapy
Allergy, 11/12/09
Relevance Score: 85%
Effects of omalizumab on markers of inflammation in patients with allergic asthma
Allergy, 11/16/09
Relevance Score: 84%
“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
Respiratory Medicine, 10/13/09
Relevance Score: 84%
Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 83%
Today in Asthma/Atopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Agreement in diagnosing occupational asthma by occupational and respiratory physicians who report to surveillance schemes for work-related ill-health
Occupational and Environmental Medicine, 12/01/09
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
Therapeutics and Clinical Risk Management, 12/01/09
Exploring Key Factors in the Choice of e-Health Using an Asthma Care Mobile Service Model
Telemedicine and e-Health, 12/01/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis
Journal of Cystic Fibrosis , 12/02/09
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 12/02/09
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer
Journal of Clinical Oncology, 12/01/09
Sponsor
Article Search
Sponsor